Dey, L.P. v. Ivax Pharmaceuticals, Inc.

PROCEEDINGS: (IN CHAMBERS) ORDER GRANTING DEFENDANTS’ MOTION TO SHORTEN THE 30-MONTH STATUTORY STAY OF APPROVAL OF EON LABS, INC.’S ABBREVIATED NEW DRUG APPLICATION UNDER 21 U.S.C. § 355(j)(5)(B)(iii) [filed 9/22/05]; DENYING IVAX PHARMACEUTICALS, INC.’S MOTION TO PRECLUDE DEY, L.P. FROM WAIVING PRIVILEGE AND INTRODUCING EVIDENCE SUPPORTING ADVICE OF COUNSEL DEFENSE [filed 9/19/05]; GRANTING DEY, L.P.’S MOTION FOR AN ORDER ESTABLISHING THE SCOPE OF PLAINTIFF’S ATTORNEY-CLIENT PRIVILEGE AND WORK PRODUCT IMMUNITY WAIVER [filed 9/20/05]; AND DENYING WITHOUT PREJUDICE DEY, L.P.’S MOTION TO…